Medtech layoffs are picking up as 2024 draws to a close. Sean Whooley, Associate Editor, and Chris Newmarker, Editor-in-Chief The medical device industry is closing out the year with a fresh round of layoffs. At this point, MassDevice has reported on more than 22,000 medtech job cuts across the industry since mid-2022. (Have a tip […]
MassDevice Earnings Roundup
Edwards projects 10% growth in first year as a purely structural heart company
Edwards Lifesciences (NYSE:EW) today announced its plans for significant growth as a purely structural heart company in 2025. The company is entering its first full year as a structural heart company following the $4.2 billion sale of its Critical Care business to BD. That sale was followed by a 3% global workforce reduction and a […]
Embecta discontinues insulin patch pump program, plans restructuring
Embecta (Nasdaq:EMBC) today announced that it’s bowing out of a significant diabetes technology market amid a new restructuring effort. Our sister site, Drug Delivery Business News, reports that the BD Diabetes spinoff is discontinuing its insulin patch pump program. This decision also includes a significant restructuring that will lead to a workforce reduction, although Embecta has […]
Boston Scientific to acquire hepatic artery infusion pump maker Intera Oncology
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed amount. Intera Oncology develops the Intera 3000 hepatic artery infusion pump and floxuridine, a chemotherapy drug. Both hold FDA approval. The pump administers hepatic artery infusion (HAI) therapy to treat tumors in the liver primarily caused by […]
Medtronic raises 2025 guidance following Q2 beats
Medtronic (NYSE:MDT) is raising its full-year guidance following strong second-quarter financial results that came in ahead of the consensus forecast. Shares of MDT were down more than 1% to $85.91 apiece in at the opening of trading today. The world’s largest medical device company reported profits of nearly $1.3 billion. That equals 99¢ per share […]
Vicarious Surgical says first surgical robot trials remain on track, analysts remain neutral
Vicarious Surgical (NYSE:RBOT) announced third-quarter results that included an update on planned clinical trials for its surgical robot. Waltham, Massachusetts–based Vicarious develops its Version 1.0 (V1.0) robot aimed at increasing the efficiency of surgical procedures. The company hopes to improve patient outcomes and reduce healthcare costs. With a novel approach, V1.0 uses proprietary, human-like surgical […]
Nevro wins CE mark for HFX iQ spinal cord stim for pain relief
Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system. HFX iQ utilizes AI, high-frequency (10 kHz) therapy and ongoing cloud insights to deliver personalized pain relief. It features an implantable pulse generator (IPG), trial stimulator and application. It includes a new, Bluetooth-enabled IPG, that […]
Solventum raises guidance again after beating The Street in Q3
Solventum (NYSE:SOLV) reported third-quarter results that came in ahead of the consensus forecast on Wall Street. However, shares of SOLV were down 3% to $72.63 apiece in mid-day trading. In its second quarterly earnings report as an independent company, the Maplewood, Minnesota–based 3M Health Care spinoff reported profits of $122 million. That equals 70¢ per […]
Baxter expects $200M hit from hurricane, decreases full-year forecast
Baxter (NYSE: BAX) today said it expects to lose out on at least $200 million worth of sales due to flooding at its North Cove manufacturing facility from Hurricane Helene. That estimate — which includes about $40 million to $50 million worth of Kidney Care sales and around $150 million to $160 million worth of […]
Insulet stock rises on Q3 beat, raised sales guidance
Insulet (Nasdaq:PODD) once again posted significant year-over-year growth as Omnipod revenues continue to rise. Our sister site, Drug Delivery Business News, reports today that the company’s third-quarter financial results include sales of $543.9 million for the three months ended Sept. 30, 2024, leading to a 49.3% bottom-line gain on a sales increase of 25.7%. The company […]
BD stock ticks up on Street-beating Q4, 2025 guidance
BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of BDX rose more than 1% to $240.06 apiece at the opening of trading today. The Franklin Lakes, New Jersey–based medtech giant reported profits of $421 million. That equals $1.45 per share on sales of […]
